BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,145 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $556,000 | +6.1% | 6,460 | 0.0% | 0.21% | -10.8% |
| Q1 2020 | $524,000 | -3.0% | 6,460 | 0.0% | 0.24% | +25.0% |
| Q4 2019 | $540,000 | -4.4% | 6,460 | 0.0% | 0.19% | -13.1% |
| Q3 2019 | $565,000 | +6.8% | 6,460 | 0.0% | 0.22% | +8.3% |
| Q2 2019 | $529,000 | +0.8% | 6,460 | 0.0% | 0.20% | -6.4% |
| Q1 2019 | $525,000 | +23.5% | 6,460 | 0.0% | 0.22% | +2.3% |
| Q4 2018 | $425,000 | +43.6% | 6,460 | +68.4% | 0.21% | +62.6% |
| Q3 2018 | $296,000 | +4.6% | 3,835 | 0.0% | 0.13% | -0.8% |
| Q2 2018 | $283,000 | +13.7% | 3,835 | 0.0% | 0.13% | +13.8% |
| Q1 2018 | $249,000 | +0.4% | 3,835 | 0.0% | 0.12% | -2.5% |
| Q4 2017 | $248,000 | +978.3% | 3,835 | +667.0% | 0.12% | +750.0% |
| Q2 2016 | $23,000 | +21.1% | 500 | 0.0% | 0.01% | +16.7% |
| Q4 2015 | $19,000 | +18.8% | 500 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $16,000 | -15.8% | 500 | 0.0% | 0.01% | -9.1% |
| Q2 2015 | $19,000 | -44.1% | 500 | 0.0% | 0.01% | -45.0% |
| Q1 2015 | $34,000 | – | 500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |